SEC Form 4 · accession 0001127602-15-009532

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP and CMO

Period of report

Mar 2, 2015

Accepted (ET)

Mar 3, 2015 · 4:11 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001062822

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Mar 2, 2015	M	13,000	—	A	39,783	D
Common Stock^F1	Mar 2, 2015	M	17,500	—	A	57,283	D
Common Stock^F1	Mar 2, 2015	M	19,750	—	A	77,033	D
Common Stock	Mar 2, 2015	F	18,266	$0.94	D	58,767	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units (Phantom Stock)^F1,F3	—	Mar 2, 2015	M	13,000	D	—	—	Common Stock	13,000	13,000	D
Restricted Stock Units (Phantom Stock)^F1,F4	—	Mar 2, 2015	M	17,500	D	—	—	Common Stock	17,500	35,000	D
Restricted Stock Units (Phantom Stock)^F1,F5	—	Mar 2, 2015	M	19,750	D	—	—	Common Stock	19,750	59,250	D

F1Each restricted stock unit represents a contingent right to receive one share of common stock.
F2Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2013 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
F4Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
F5Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.